发明名称 |
LAPATINIB FOR TREATING CANCER |
摘要 |
Methods are provided of treating a human for cancer comprising administering at least one dose of lapatinib, or a pharmaceutically acceptable salt or composition thereof, to a patient, wherein said patient does not have one or more allelic polymorphisms selected from the group of: HLA-DQA1*0201, HLA-DQB1*0202, and HLA-DRB1*0701. Patients may also be free of genotypes in TNXB; rs12153855 and/or rs17207923. |
申请公布号 |
RS55074(B1) |
申请公布日期 |
2016.12.30 |
申请号 |
RS2016P000681 |
申请日期 |
2010.08.20 |
申请人 |
NOVARTIS AG |
发明人 |
BING, NAN;BRILEY, LINDA PERRY;BUDDE, LAURA R.;COX, CHARLES J.;SPRAGGS, COLIN F. |
分类号 |
A61K31/517;A61K45/06;A61P35/00;C12Q1/68;G01N33/569;G01N33/574 |
主分类号 |
A61K31/517 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|